We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 37.72%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
+27.34%
1 Year Est. Return
+37.72%
3 Year Est. Return
+117.83%
5 Year Est. Return
+153.46%
10 Year Est. Return
+660.32%
AUM
$178B
AUM Growth
+$32.9B
Cap. Flow
-$2.06B
Cap. Flow %
-1.16%
Top 10 Hldgs %
23.08%
Holding
1,423
New
132
Increased
511
Reduced
643
Closed
125

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$530M
2
ABBV icon
AbbVie
ABBV
+$429M
3
BSX icon
Boston Scientific
BSX
+$292M
4
SNAP icon
Snap
SNAP
+$241M
5
RPRX icon
Royalty Pharma
RPRX
+$223M

Sector Composition

Rank Sector Weight
1 Technology 30.65%
2 Healthcare 19.7%
3 Consumer Discretionary 10.81%
4 Financials 9.9%
5 Communication Services 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCB
426
United Community Banks
UCB
$4.27B
$65.1M 0.04%
3,237,592
+626,096
+24% +$12M
BKH icon
427
Black Hills Corp
BKH
$5.69B
$64.8M 0.04%
1,143,678
+74,525
+7% +$4.51M
NTR icon
428
Nutrien
NTR
$33.3B
$63.8M 0.04%
1,989,665
-146,736
-7% -$5.11M
LUMN icon
429
Lumen
LUMN
$6.38B
$63.8M 0.04%
6,359,522
+3,667,797
+136% +$36.7M
DRE
430
DELISTED
Duke Realty Corp.
DRE
$63.4M 0.04%
1,791,495
+112,581
+7% +$3.84M
CUB
431
DELISTED
Cubic Corporation
CUB
$63.3M 0.04%
1,318,236
+723,418
+122% +$29.4M
SWK icon
432
Stanley Black & Decker
SWK
$14.6B
$63.3M 0.04%
454,257
-23,800
-5% -$2.87M
GRFS
433
Grifois
GRFS
$5.44B
$63M 0.04%
3,449,966
-573,258
-14% -$11.4M
ES icon
434
Eversource Energy
ES
$28.4B
$62.9M 0.04%
755,583
-37,387
-5% -$3.1M
CSTM icon
435
Constellium
CSTM
$3.96B
$62.8M 0.04%
8,181,241
-313,296
-4% -$2.28M
UBSI icon
436
United Bankshares
UBSI
$6.71B
$62.7M 0.04%
2,267,250
+807,232
+55% +$21.7M
COLM icon
437
Columbia Sportswear
COLM
$3.3B
$62.5M 0.04%
775,378
+515,677
+199% +$37.6M
DTE icon
438
DTE Energy
DTE
$30.4B
$61.6M 0.03%
673,472
-326,426
-33% -$28.9M
NOMD icon
439
Nomad Foods
NOMD
$1.7B
$61.6M 0.03%
2,872,036
-893,626
-24% -$18.6M
CFG icon
440
Citizens Financial Group
CFG
$30.8B
$61.1M 0.03%
2,422,320
-24,607
-1% -$558K
BMY.RT
441
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$60.9M 0.03%
17,001,043
+3,496,513
+26% +$12.6M
SAGE
442
DELISTED
Sage Therapeutics
SAGE
$60.7M 0.03%
1,459,676
+71,881
+5% +$2.61M
AES icon
443
AES
AES
$10.6B
$60.7M 0.03%
4,185,963
-2,587,090
-38% -$34M
TVTX icon
444
Travere Therapeutics
TVTX
$5.2B
$59.4M 0.03%
2,912,069
+2,752,874
+1,729% +$43.8M
CAG icon
445
Conagra Brands
CAG
$7.38B
$58.8M 0.03%
1,671,731
+859,735
+106% +$28.7M
SGEN
446
DELISTED
Seagen Inc. Common Stock
SGEN
$58.7M 0.03%
345,569
+239,861
+227% +$35.8M
INVH icon
447
Invitation Homes
INVH
$17.9B
$58.7M 0.03%
2,132,141
-855,820
-29% -$21.4M
PFPT
448
DELISTED
Proofpoint, Inc.
PFPT
$58.5M 0.03%
526,935
-104,592
-17% -$11.9M
TWNK
449
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$58.4M 0.03%
4,781,059
+226,032
+5% +$2.67M
WSFS icon
450
WSFS Financial
WSFS
$4.2B
$58.3M 0.03%
2,030,659
+155,934
+8% +$4.13M

Similar funds

Janus Henderson Group's Q2 2020 Portfolio in Review

As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
  • Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
  • Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
  • Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
  • Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
  • Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
  • Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.

Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.